Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Scancell Hldgs Plc
SCLPCurrent price
13.38 GBX
+0.0000000029 GBX (+0.00%)
Last closed
13.38 GBX
Company
www.scancell.co.uk
ISIN
GB00B63D3314
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
124 440 980 GBX
Yield for 12 month
+11.46 %
1Y
3Y
5Y
10Y
15Y
SCLP
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, melanoma, ovarian, lung, and pancreatic cancers; and Modi-2, which targets homocitrullinated cancer antigens. In addition, the company focuses to develop SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom. Address: Bellhouse Building, Oxford, United Kingdom, OX4 4GD
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 905.94 GBXP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+527 553 444 GBX
Current Quarter
–
Last Quarter
–
Current Year
-96 683 096 GBX
Last Year
+475 008 233 GBX
Current Quarter
-53 245 783 GBX
Last Quarter
-43 437 313 GBX
Key Figures SCLP
1 year
3 years
5 years
10 years
EBITDA
-17 721 194 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-45.28 %
PEG Ratio
–
Return On Equity TTM
-269.84 %
Wall Street Target Price
1 905.94 GBX
Revenue TTM
–
Book Value
-0.004 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.01 GBX
Diluted Eps TTM
-0.01 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SCLP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SCLP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
10:1
Payout Ratio
–
Last Split Date
26.07.2011
Dividend Date
–
Stock Valuation SCLP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
21.1686
Price Sales TTM
16.2623
Enterprise Value EBITDA
-10.4817
Price Book MRQ
8.887
Financials SCLP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SCLP
For 52 weeks
8.61 GBX
19.77 GBX
50 Day MA
14.94 GBX
Shares Short Prior Month
–
200 Day MA
12.31 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart